Go Pro

Corient Private Wealth LP Raises Holdings in The Clorox Company $CLX

Clorox logo with Consumer Staples background
Image from MarketBeat Media, LLC.

Key Points

  • Corient Private Wealth LP increased its Clorox stake by 204.6% in the second quarter, bringing its holdings to 71,391 shares valued at approximately $6.8 million. Institutional investors collectively own 78.53% of the company.
  • Analyst sentiment remains cautious: Clorox has an average “Reduce” rating, with 13 analysts at “Hold” and four at “Sell.” The consensus price target is $101.40, while Jefferies cut its target from $125 to $98.
  • Clorox beat quarterly expectations with $1.66 in EPS and $1.95 billion in revenue, though revenue fell 2% year over year. The company raised its quarterly dividend to $1.25, equivalent to a 5.9% annualized yield.
  • Interested in Clorox? Here are five stocks we like better.

Corient Private Wealth LP increased its stake in shares of The Clorox Company (NYSE:CLX - Free Report) by 204.6% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 71,391 shares of the company's stock after purchasing an additional 47,950 shares during the period. Corient Private Wealth LP owned 0.06% of Clorox worth $6,814,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of CLX. Ancora Advisors LLC acquired a new stake in shares of Clorox during the 2nd quarter worth about $28,000. Avalon Trust Co acquired a new position in shares of Clorox in the second quarter valued at approximately $29,000. Markowski Investments purchased a new position in shares of Clorox during the second quarter valued at approximately $30,000. Root Financial Partners LLC lifted its stake in shares of Clorox by 83.8% during the first quarter. Root Financial Partners LLC now owns 318 shares of the company's stock valued at $33,000 after buying an additional 145 shares during the period. Finally, Western Wealth Management LLC acquired a new stake in Clorox during the first quarter worth approximately $35,000. Institutional investors and hedge funds own 78.53% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms have commented on CLX. Jefferies Financial Group cut shares of Clorox from a "buy" rating to a "hold" rating and lowered their target price for the stock from $125.00 to $98.00 in a research note on Tuesday, July 28th. Deutsche Bank Aktiengesellschaft set a $98.00 price target on Clorox in a research note on Tuesday, August 4th. BNP Paribas Exane lowered their price objective on Clorox from $97.00 to $95.00 and set a "neutral" rating for the company in a research report on Monday, July 20th. Weiss Ratings reiterated a "hold (c-)" rating on shares of Clorox in a research note on Friday, July 10th. Finally, UBS Group reiterated a "neutral" rating on shares of Clorox in a research report on Friday, September 11th. Thirteen equities research analysts have rated the stock with a Hold rating and four have assigned a Sell rating to the stock. According to data from MarketBeat.com, Clorox currently has an average rating of "Reduce" and a consensus target price of $101.40.

Get Our Latest Analysis on CLX

Clorox Trading Up 0.1%

Shares of CLX opened at $84.98 on Friday. The Clorox Company has a twelve month low of $83.76 and a twelve month high of $128.90. The firm has a market capitalization of $10.28 billion, a P/E ratio of 17.63, a price-to-earnings-growth ratio of 2.66 and a beta of 0.56. The company has a current ratio of 0.66, a quick ratio of 0.38 and a debt-to-equity ratio of 15.80. The stock's fifty day simple moving average is $98.54 and its 200 day simple moving average is $99.24.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings results on Monday, August 3rd. The company reported $1.66 EPS for the quarter, topping the consensus estimate of $1.64 by $0.02. Clorox had a return on equity of 522.23% and a net margin of 8.74%.The company had revenue of $1.95 billion during the quarter, compared to analyst estimates of $1.91 billion. During the same period in the prior year, the firm posted $2.87 earnings per share. The firm's revenue was down 2.0% on a year-over-year basis. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. On average, equities research analysts forecast that The Clorox Company will post 5.8 earnings per share for the current year.

Clorox Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, August 28th. Stockholders of record on Wednesday, August 12th were paid a $1.25 dividend. The ex-dividend date of this dividend was Wednesday, August 12th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 5.9%. This is a boost from Clorox's previous quarterly dividend of $1.24. Clorox's payout ratio is 103.73%.

Clorox Profile

(Free Report)

The Clorox Company NYSE: CLX is a consumer products company that develops, manufactures and markets household, health and wellness, and lifestyle products. Its portfolio includes cleaning and disinfecting products, laundry and home-care items, food products, personal-care products, water-filtration systems, charcoal, and cat litter.

Clorox's brands include Clorox bleach and disinfecting products, Pine-Sol, Fresh Step and Scoop Away, Kingsford, Brita, Burt's Bees, Hidden Valley, and products marketed under the Glad name.

Further Reading

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX - Free Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Clorox Right Now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines